Canara HSBC Life Insurance Company
Canara HSBC Life Insurance Company
InsuranceKey Fundamentals
MicrocapLife InsuranceInsuranceTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is expected to give good quarter
- Company has been maintaining a healthy dividend payout of 32.0%
Weaknesses
5- Stock is trading at 8.83 times its book value
- The company has delivered a poor sales growth of 4.55% over past five years.
- Tax rate seems low
- Company has a low return on equity of 8.08% over last 3 years.
- Earnings include an other income of Rs.85.3 Cr.
Growth Rate
AI Analysis — Bull vs Bear
Canara HSBC Life Insurance trades at a market cap of ₹14,156 Cr with a PE of 110x and P/B of 8.83x, reflecting premium valuations. The company has delivered modest compounded profit growth of 12% over 3 years and maintains an ROE of approximately 8%, while sales growth over 5 years has been subdued at around 5%.
- Company is expected to deliver a good upcoming quarter, suggesting near-term earnings momentum
- Healthy dividend payout ratio of 32.0%, indicating shareholder-friendly capital return policy
- Compounded profit growth of 12% over 3 years outpaces the 11% sales CAGR over the same period, pointing to margin improvement
- TTM revenue growth of 9% shows an acceleration from the 5-year sales CAGR of 5%, suggesting improving business traction
- ROE has improved to 8% in the last year from a 5-year average of 7%, indicating gradual return profile improvement
- Insurance penetration in India remains low relative to global averages, providing a long structural growth runway for life insurers
- Parentage of Canara Bank (extensive branch network) and HSBC offers a strong bancassurance distribution channel advantage
- PE ratio of 110x is significantly elevated, demanding substantial future earnings growth to justify current valuations
- P/B ratio of 8.83x is steep for a company generating only 8% ROE, implying the stock prices in far more profitability than currently delivered
- 5-year compounded sales growth of just 5% reflects weak top-line momentum over a meaningful period
- 3-year average ROE of 8.08% is low for the life insurance sector, where peers often deliver mid-teens returns
- Earnings quality is a concern as other income of ₹85.3 Cr forms a notable component of reported profits
- Apparently low tax rate raises questions about the sustainability and quality of reported earnings
- Dividend yield of just 0.26% offers minimal income cushion despite the 32% payout ratio, a function of the high stock price relative to earnings
- 5-year compounded profit growth of only 6% underscores historically sluggish bottom-line expansion
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- IRDAI ₹1 crore misselling fine Sep 10
IRDAI penalized Canara HSBC Life ₹1 crore for policy misselling, citing violations of policyholder interest regulations. Regulatory action signals compliance gaps.
- CFO resignation after 7 years Aug 31
CFO Tarun Rustagi resigned effective Aug 31, 2026, with last working day Nov 24, 2026, ending a seven-year tenure that included the company's market listing. Leadership vacuum at a key finance role adds near-term uncertainty.
- HSBC IBU agency deal signed Aug 25
Canara HSBC Life entered a corporate agency agreement with HSBC IBU for insurance distribution in GIFT City. The related-party transaction at arm's length expands the company's distribution reach into the international financial services centre.
- ₹0.40 dividend approved at AGM Aug 20
Shareholders approved a ₹0.40 per share dividend for FY26 at the 19th AGM on Aug 20, 2026. FY27 related party transactions were also cleared, ensuring business continuity.
- Two independent directors reappointed Sep 9
Board reappointed Dr Kishore Kumar Sansi and Mr Supratim Bandyopadhyay as independent directors for three-year terms on Sep 9, 2026, subject to shareholder approval. Ensures board continuity and governance stability.
TL;DR: Canara HSBC Life is expanding distribution via a new HSBC IBU agency deal in GIFT City and maintaining shareholder returns with a ₹0.40 dividend. However, the ₹1 crore IRDAI fine for misselling raises compliance concerns, and the CFO's departure after seven years creates a leadership gap at a critical juncture. The trend is mixed — growth levers are intact but execution risks have risen with regulatory scrutiny and senior management transition to watch in coming quarters.
Quarterly Results
| Particulars | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 3,323 | 1,516 | 2,783 | 3,632 | 2,348 | 4,202 | 1,374 | 4,351 |
| Expenses | 3,317 | 1,539 | 2,749 | 3,625 | 2,332 | 4,272 | 1,258 | 4,351 |
| Operating Profit | 6 | -23 | 34 | 6 | 16 | -70 | 116 | 0 |
| OPM % | 0.2% | -1.5% | 1.2% | 0.2% | 0.7% | -1.7% | 8% | 0% |
| Other Income | 37 | 51 | 1 | 20 | 30 | 101 | -77 | 32 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 43 | 28 | 35 | 26 | 45 | 31 | 39 | 32 |
| Tax % | 15% | -4% | 8% | 10% | 10% | 10% | 10% | 11% |
| Net Profit | 37 | 29 | 32 | 23 | 41 | 28 | 35 | 28 |
| EPS in Rs | 0.39 | 0.31 | 0.34 | 0.25 | 0.43 | 0.29 | 0.37 | 0.3 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 3,074 | 9,253 | 8,496 | 8,435 | 11,841 | 10,710 | 11,556 | 12,275 |
| Expenses | 3,059 | 9,323 | 8,726 | 8,471 | 11,705 | 10,578 | 11,424 | 12,214 |
| Operating Profit | 15 | -71 | -230 | -36 | 136 | 131 | 132 | 61 |
| OPM % | 0.5% | -0.8% | -2.7% | -0.4% | 1.1% | 1.2% | 1.1% | 0.5% |
| Other Income | 104 | 184 | 256 | 155 | 11 | 19 | 29 | 85 |
| Interest | 6 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 8 | 13 | 17 | 19 | 23 | 22 | 20 | 0 |
| PBT | 105 | 95 | 10 | 100 | 124 | 128 | 141 | 146 |
| Tax % | 0% | 0% | 0% | 9% | 9% | 9% | 10% | — |
| Net Profit | 105 | 95 | 10 | 91 | 113 | 117 | 127 | 131 |
| EPS in Rs | 1.11 | 1 | 0.11 | 0.96 | 1.19 | 1.23 | 1.33 | 1.39 |
| Div. Payout % | 0% | 0% | 278% | 31% | 34% | 32% | 30% | — |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 950 | 950 | 950 | 950 | 950 | 950 | 950 |
| Reserves | 239 | 330 | 340 | 403 | 469 | 567 | 655 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 250 |
| Other Liabilities | 14,757 | 21,306 | 25,925 | 29,957 | 37,332 | 41,397 | 46,201 |
| Total Liabilities | 15,946 | 22,586 | 27,215 | 31,310 | 38,751 | 42,914 | 48,057 |
| Fixed Assets | 32 | 37 | 70 | 73 | 77 | 42 | 31 |
| CWIP | 4 | 7 | 4 | 5 | 2 | 4 | 6 |
| Investments | 15,374 | 21,871 | 26,266 | 30,179 | 37,357 | 41,166 | 46,118 |
| Other Assets | 536 | 671 | 875 | 1,053 | 1,314 | 1,702 | 1,901 |
| Total Assets | 15,946 | 22,586 | 27,215 | 31,310 | 38,751 | 42,914 | 48,057 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | — | 2,340 | 1,998 | 2,592 | 2,310 | 1,208 | 3,534 |
| Investing | — | -2,236 | -1,929 | -2,518 | -2,045 | -714 | -3,666 |
| Financing | — | 0 | 0 | -28 | -48 | -19 | 212 |
| Net Cash Flow | — | 103 | 69 | 46 | 218 | 474 | 80 |
| Free Cash Flow | — | 2,319 | 1,980 | 2,568 | 2,283 | 1,197 | 3,523 |
| CFO/OP | — | -3,306 | -871 | -7,284 | 1,708 | 930 | 2,687 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Working Capital Days | -4 | -15 | -6 | -5 | -3 | -2 | -5 |
| ROCE % | — | 8% | 1% | 8% | 9% | 9% | 8% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Canara HSBC Life Insurance Company insights
33 extracted metrics + investor summaries across FY20–FY27.
Documents
Frequently Asked Questions about Canara HSBC Life Insurance Company
What does Canara HSBC Life Insurance Company Ltd do?
Where is Canara HSBC Life Insurance Company Ltd (CANHLIFE) listed?
Which sector does Canara HSBC Life Insurance Company Ltd belong to?
What is the market capitalisation of Canara HSBC Life Insurance Company Ltd?
What is the PE ratio of Canara HSBC Life Insurance Company Ltd?
What is the 52-week high and low of Canara HSBC Life Insurance Company Ltd?
Does Canara HSBC Life Insurance Company Ltd pay dividends?
What is the Return on Equity (ROE) of Canara HSBC Life Insurance Company Ltd?
Company Information
Canara HSBC Life Insurance is an Indian life insurance company, headquartered in Gurugram. In 2008, Canara HSBC Life Insurance was a JV between Canara Bank (51%), HSBC Insurance (Asia Pacific) Holdings Limited (26%) and PNB (23%). In 2022, the company renamed itself as Canara HSBC Life Insurance after the exit of its third partner, PNB.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CANHLIFE.md for Canara HSBC Life Insurance Company Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.